PDC*line Pharma
Novel class of off-the-shelf cancer immunotherapies based on a proprietary Plasmacytoid Dendritic Cell line pre-loaded with peptides
Stem Cell, Cellular Therapies & Products
Location
La Tronche, France
Cancers And Other Neoplasms
Platform: mRNA-based therapeutics
Developing novel mRNA-based cancer therapies targeting solid tumors with high unmet need.
Immune System Diseases
Platform: Antibody-drug conjugates
Precision medicine approach for autoimmune disorders using proprietary antibody-drug conjugate technology.
Nervous System Diseases
Platform: Small molecule inhibitors
Targeting neurological disorders through blood-brain barrier penetrant small molecules.
Premium Feature: Therapeutic Areas
Upgrade to access detailed therapeutic area information for this company and unlock all premium features.